Skip to main content

Table 3 Clinical measurements for SPN patients from index date by subsequent clinic visit

From: Understanding the patient journey to diagnosis of lung cancer

Visit Characteristics

Patients with SPN and no diagnosis of Lung Cancer

Visit one following index visit

Visit two following index visit

Visit three following index visit

Visit 4 + all visits up to end of study period

 

N = 15,978

N = 14,366

N = 13,009

N = 11,715

N = 10,476

Days (median (IQR)) between visits

 

11 (3, 42)

16 (4, 50)

17 (5, 49)

32.5 (19.3, 56.1)

Cumulative days from index visit (median (IQR))

 

11 (3, 42)

38 (12, 104)

67 (25, 151)

196.4 (148.6, 251.5)

LDCT scan

26 (0.16)

4 (0.03)

3 (0.02)

3 (0.03)

6 (0.06)

Chest Imaging

9874 (61.80)

4868 (33.89)

3623 (27.85)

2931 (25.02)

5717 (54.57)

E&M

6129 (38.36)

9632 (67.05)

9483 (72.90)

8886 (75.85)

9972 (95.19)

EBUS/mediastinoscopy

28 (0.18)

34 (0.24)

23 (0.18)

25 (0.21)

75 (0.72)

Biopsya

187 (1.17)

157 (1.09)

143 (1.10)

96 (0.82)

399 (3.81)

PET CT

99 (0.62)

101 (0.70)

100 (0.77)

62 (0.53)

284 (2.71)

Brain MRI

104 (0.65)

148 (1.03)

107 (0.82)

95 (0.81)

576 (5.50)

Bone scan

7 (0.04)

12 (0.08)

21 (0.16)

15 (0.13)

77 (0.74)

SPN diagnosis

15,978 (100.00)

3597 (25.04)

2432 (18.69)

1818 (15.52)

3558 (33.96)

Loss to follow up, N (%)b

 

1612 (10.09)

1357 (8.49)

1294 (8.10)

1239 (7.75)

  1. abiopsies do not include EBUS/mediastinoscopy
  2. b% relative to the total number of cancer patients (N = 15,978)